Anti-CD80 [IDEC-114 (Galiximab)], Human IgG1, Fc Silent(TM), lambda, Clone: [IDEC-114 Galiximab], Monoclonal

Produktübersicht

• Artikelname: Anti-CD80 [IDEC-114 (Galiximab)], Human IgG1, Fc Silent(TM), lambda, Clone: [IDEC-114 Galiximab], Monoclonal
• Artikelnummer: ABA-AB00736-10.3
• Hersteller Artikelnummer: Ab00736-10.3
• Alternativnummer: ABA-AB00736-10.3
• Hersteller: Absolute Antibody
• Wirt: Human
• Kategorie: Antikörper
• Applikation: Blocking, ELISA, FC, IHC, IP, WB
• Spezies Reaktivität: Human
• Alternative Synonym: B7-1, T-lymphocyte activation antigen CD80, Activation B7-1 antigen, BB1, CTLA-4 counter-receptor B7.1, B7

Produktbeschreibung

Galiximab was prepared by immunizing cynomolgus monkeys with recombinant CD80 antigen. The variable regions of the light and heavy chains were then cloned by being incorporated into a cassette vector (N5LG1) containing human constant region genes and subsequently transfected into the Dg44 CHO cell line (Hariharan K, 2013)

Produkteigenschaften

• Klonalität: Monoclonal
• Klon-Bezeichnung: [IDEC-114 Galiximab]
• Isotyp: IgG1
• UniProt: P33681
• Puffer: PBS with 0.02% Proclin 300.
• Quelle: Human
• Target-Kategorie: CD80
• Antibody Type: Recombinant Antibody